Covalon Technologies's revenue per share for the
three
months ended in Dec. 2023 was $0.14.
Covalon Technologies's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.75.
Warning Sign:
Covalon Technologies Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Covalon Technologies was 32.80% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 27.10% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -6.20% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 2.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Covalon Technologies's Revenue per Share or its related term are showing as below:
CVALF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -27.4 Med: 12.4 Max: 46.3
Current: 27.1
During the past 13 years, Covalon Technologies's highest 3-Year average Revenue Per Share Growth Rate was 46.30% per year. The lowest was -27.40% per year. And the median was 12.40% per year.
CVALF's 3-Year Revenue Growth Rate is ranked better than 75.87% of 779
companies
in the Biotechnology industry
Industry Median: 3.7
vs CVALF: 27.10
Covalon Technologies Revenue per Share Historical Data
The historical data trend for Covalon Technologies's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Covalon Technologies's Revenue per Share
For the Biotechnology subindustry, Covalon Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Covalon Technologies's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Covalon Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Covalon Technologies's PS Ratio falls into.
Covalon Technologies Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Covalon Technologies's Revenue Per Share for the fiscal year that ended in Sep. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Covalon Technologies (OTCPK:CVALF) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Covalon Technologies Revenue per Share Related Terms
Thank you for viewing the detailed overview of Covalon Technologies's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Covalon Technologies (Covalon Technologies) Business Description
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CVALF has been successfully added to your 